作者:
Dami A,Collier [1]
;
Anna,De Marco [2]
;
Isabella A T M,Ferreira [3]
;
Bo,Meng [4]
;
Rawlings P,Datir [1]
;
Alexandra C,Walls [2]
;
Steven A,Kemp [1]
;
Jessica,Bassi [2]
;
Dora,Pinto [1]
;
Chiara,Silacci-Fregni [2]
;
Siro,Bianchi [3]
;
M Alejandra,Tortorici [5]
;
John,Bowen [1]
;
Katja,Culap [2]
;
Stefano,Jaconi [3]
;
Elisabetta,Cameroni [4]
;
Gyorgy,Snell [4]
;
Matteo S,Pizzuto [4]
;
Alessandra Franzetti,Pellanda [4]
;
Christian,Garzoni [5]
;
Agostino,Riva [5]
;
CITIID-NIHR BioResource COVID-19 Collaboration [4]
;
Anne,Elmer [4]
;
Nathalie,Kingston [4]
;
Barbara,Graves [6]
;
Laura E,McCoy [4]
;
Kenneth G C,Smith [7]
;
John R,Bradley [7]
;
Nigel,Temperton [8]
;
Lourdes,Ceron-Gutierrez [9]
;
Gabriela,Barcenas-Morales [10]
;
COVID-19 Genomics UK (COG-UK) Consortium [10]
;
William,Harvey [3]
;
Herbert W,Virgin [1]
;
Antonio,Lanzavecchia [2]
;
Luca,Piccoli [2]
;
Rainer,Doffinger [10]
;
Mark,Wills [11]
;
David,Veesler [12]
;
Davide,Corti [12]
;
Ravindra K,Gupta [13]
作者单位:
Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.
[1]
Department of Medicine, University of Cambridge, Cambridge, UK.
[2]
Division of Infection and Immunity, University College London, London, UK.
[3]
Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
[4]
Department of Biochemistry, University of Washington, Seattle, WA, USA.
[5]
Vir Biotechnology, San Francisco, CA, USA.
[6]
Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, Lugano, Switzerland.
[7]
Division of Infectious Diseases, Luigi Sacco Hospital, University of Milan, Milan, Italy.
[8]
NIHR Cambridge Clinical Research Facility, Cambridge, UK.
[9]
NIHR Bioresource, Cambridge, UK.
[10]
University of Kent, Canturbury, UK.
[11]
Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.
[12]
Laboratorio de Inmunologia, UNAM, Cuautitlán, Mexico.
[13]
Institute of Biodiversity, University of Glasgow, Glasgow, UK.
[14]
Department of Haematology, University of Cambridge, Cambridge, UK.
[15]
Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. dcorti@vir.bio.
[16]
Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK. rkg20@cam.ac.uk.
[17]
Department of Medicine, University of Cambridge, Cambridge, UK. rkg20@cam.ac.uk.
[18]
Department of Haematology, University of Cambridge, Cambridge, UK. rkg20@cam.ac.uk.
[19]
University of KwaZulu Natal, Durban, South Africa. rkg20@cam.ac.uk.
[20]
Africa Health Research Institute, Durban, South Africa. rkg20@cam.ac.uk.
[21]
Department of Infectious Diseases, Cambridge University Hospitals NHS Trust, Cambridge, UK. rkg20@cam.ac.uk.
[22]
DOI
10.1038/s41586-022-05103-3
PMID
35864232
发布时间
2024-03-13
- 浏览4

Nature
Nature
E24页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文